TAG ARCHIVES FOR investigators

25
Mar2019

How should a “reasonable” HRPP approach key information?

Tags:
25 Mar
Comments: 1

“One person’s flexibility is another person’s ambiguity.”

I kept going back to this comment, articulated by Carrie Wolinetz (NIH), as I helped my HRPP prepare for the revised Common Rule implementation in January.  Although Dr. Wolinetz was referring to the NIH’s Genomic Data Sharing Policy, the phrase is a perfect expression of my thoughts on the “concise and focused presentation of the key information” that now must appear at the beginning of consent forms.

This topic was addressed at the AER18 plenary session “To Participate or Not to Participate, that Is the Question.” Moderated by Ivor Pritchard (OHRP), panelists Celia Fisher (Fordham University), Jonathan [...] Read more

11
Nov2014

Supporting Your IRB: It’s Not Just About the Board

Tags:
11 Nov
No comments

by Rebecca S. Ohnemus, MAA, CRA, Research Officer at University of the Incarnate Word

As IRB administrators, we find ourselves on the frontlines. Whether you’re a director, administrative support person, or anywhere in between, an incredible amount of time is consumed facilitating the transfer of information between the IRB and your institution’s research community.

If all a [...] Read more

16
Sep2014

PRIM&R’s Response to the FDA’s Draft Guidance on Informed Consent

Tags:
16 Sep
No comments

by Avery Avrakotos, Education and Policy Manager

PRIM&R has long been committed to the protection of the rights and welfare of human subjects, and strongly believes that informed consent is an essential mechanism for providing potential subjects with the information they need to make considered, autonomous decisions about research participation.

In July, the US Food and Drug Administration (FDA) announced it [...] Read more

22
Jul2014

Working Together to Advance Science and Protect Participants

Tags:
22 Jul
No comments

by Veena Joshi, PhD, Independent Consultant, India

During my previous job at a tertiary hospital in India, a pediatrician from the institution approached the IRB office with a grant proposal. He wished to conduct a study with children under 12 years of age. While he had reviewed information online about the necessary documentation and regulatory requirements, he still sought the help of the IRB office since it was his first time serving as a principal investigator (PI).

Upon reviewing his documents, the IRB administrative staff found that the assent form was missing. The PI was not aware that an assent form [...] Read more